Clinical Trials
6 trialsNCT05457257 2026-04-21
Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations
AstraZeneca
Phase 4 Active not recruiting
NCT06121401 2025-09-17
IOLANTHE
Mario Negri Institute for Pharmacological Research
Phase 4 Active not recruiting
NCT04330040 2025-03-10
SOLI
AstraZeneca
Phase 4 Completed
NCT05078671 2024-06-12
PROACTIVE
Radboud University Medical Center
Phase 4 Recruiting
NCT05949424 2023-11-29
OPTI-DOSE
University Medical Center Groningen
Phase 4 Unknown
NCT02476968 2022-09-10
ORZORA
AstraZeneca
Phase 4 Completed